The presentation will focus on the unique complexities of topical semi-solid products containing microparticles and describe the impact of polymers (and other excipients) on the products’ structural complexity which in turn impacts bioavailability, and thereby creates potential challenges with the development of bioequivalence (BE) approaches for such products.

Track: Formulations

Presentation Level: Intermediate (requires some knowledge of the topic)

Target Audience by Industry Segment:
> Pharmaceutical - Generic Drugs

Target Audience by Role:
> Formulations
> Commercial - Operations / Production
> Research & Development
> Quality

Note: Presentations are available for on-demand viewing for 21 days after purchase.